Molecular analysis of TCR and peptide/MHC interaction using P18-I10-derived peptides with a single D-amino acid substitution

Biophysical Journal

Volumn 92, Issue 7, 2007, Pages 2570-2582

  Nakagawa, Yohko ^a   Kikuchi, Hiroto ^a   Takahashi, Hidemi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DNA SEQUENCE; FEMALE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS;

HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

EID: 34047260396     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.106.095208     Document Type: Article

References (47)

1. Garboczi, D. N., P. Ghosh, U. Utz, Q. R. Fan, W. E. Biddison, and D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 384:134-141.
2. Garcia, K. C., M. Degano, R. L. Stanfield, A. Brunmark, M. R. Jackson, P. A. Peterson, L. Teyton, and I. A. Wilson. 1996. An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science. 274:209-219.
3. Garboczi, D. N., and W. E. Biddison. 1999. Shapes of MHC restriction. Immunity. 10:1-7.
4. Hennecke, J., and D. C. Wiley. 2001. T cell receptor-MHC interactions up close. Cell. 104:1-4.
5. Reiser, J. B., C. Gregoire, C. Darnault, T. Mosser, A. Guimezanes, A. M. Schmitt-Verhulst, J. C. Fontecilla-Camps, G. Mazza, B. Malissen, and D. Housset. 2002. A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. Immunity. 16:345-354.
6. Garcia, K. C., M. Degano, L. R. Pease, M. Huang, P. A. Peterson, L. Teyton, and I. A. Wilson. 1998. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science. 279:1166-1172.
7. Takahashi, H., J. Cohen, A. Hosmalin, K. B. Cease, R. Houghten, J. L. Cornette, C. DeLisi, B. Moss, R. N. Germain, and J. A. Berzofsky. 1988. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA. 85:3105-3109.
8. Takeshita, T., H. Takahashi, S. Kozlowski, J. D. Ahlers, C. D. Pendleton, R. L. Moore, Y. Nakagawa, K. Yokomuro, B. S. Fox, and D. H. Margulies. 1995. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule. J. Immunol. 154:1973-1986.
9. Takahashi, H., S. Merli, S. D. Putney, R. Houghten, B. Moss, R. N. Germain, and J. A. Berzofsky. 1989. A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. Science. 246:118-121.
10. Takahashi, H., Y. Nakagawa, C. D. Pendleton, R. A. Houghten, K. Yokomuro, R. N. Germain, and J. A. Berzofsky. 1992. Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant. Science. 255:333-336.
11. Shirai, M., C. D. Pendleton, and J. A. Berzofsky. 1992. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules. J. Immunol. 148:1657-1667.
12. Palker, T. J., M. E. Clark, A. J. Langlois, T. J. Matthews, K. J. Weinhold, R. R. Randall, D. P. Bolognesi, and B. F. Haynes. 1988. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc. Natl. Acad. Sci. USA. 85:1932-1936.
13. Rusche, J. R., K. Javaherian, C. McDanal, J. Petro, D. L. Lynn, R. Grimaila, A. Langlois, R. C. Gallo, L. O. Arthur, P. J. Fischinger, D. P. Bolognesi, S. D. Putney, and T. J. Matthews 1988. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc. Natl. Acad. Sci. USA. 85:3198-3202.
14. Goudsmit, J., C. Debouck, R. H. Meloen, L. Smit, M. Bakker, D. M. Asher, A. V. Wolff, C. J. Gibbs, Jr., and D. C. Gajdusek. 1988. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc. Natl. Acad. Sci. USA. 85:4478-4482.
15. Takahashi, H., R. N. Germain, B. Moss, and J. A. Berzofsky. 1990. An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself. J. Exp. Med. 171:571-576.
16. Clerici, M., D. R. Lucey, R. A. Zajac, R. N. Boswell, H. M. Gebel, H. Takahashi, J. A. Berzofsky, and G. M. Shearer. 1991. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J. Immunol. 146:2214-2219.
17. Takahashi, H., R. Houghten, S. D. Putney, D. H. Margulies, B. Moss, R. N. Germain, and J. A. Berzofsky. 1989. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein. J. Exp. Med. 170:2023-2035.
18. Corr, M., L. F. Boyd, E. A. Padlan, and D. H. Margulies. 1993. H-2Dd exploits a four residue peptide binding motif. J. Exp. Med. 178:1877-1892.
19. Jorgensen, J. L., U. Esser, B. Fazekas de St Groth, P. A. Reay, and M. M. Davis. 1992. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature. 355:224-230.
20. Cease, K. B., H. Margalit, J. L. Cornette, S. D. Putney, W. G. Robey, C. Ouyang, H. Z. Streicher, P. J. Fischinger, R. C. Gallo, C. DeLisi, and J. A. Berzofsky. 1987. Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide. Proc. Natl. Acad. Sci. USA. 84:4249-4253.
21. Boehncke, W. H., T. Takeshita, C. D. Pendleton, R. A. Houghten, S. Sadegh-Nasseri, L. Racioppi, J. A. Berzofsky, and R. N. Germain. 1993. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. J. Immunol. 150:331-341.
22. Zhang, W., S. Honda, F. Wang, T. P. DiLorenzo, A. M. Kalergis, D. A. Ostrov, and S. G. Nathenson. 2001. Immunobiological analysis of TCR single-chain transgenic mice reveals new possibilities for interaction between CDR3alpha and an antigenic peptide bound to MHC class I. J. Immunol. 167:4396-4404.
23. + cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int. Immunol. 5:849-857.
24. + cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism? J. Exp. Med. 183:879-889.
25. Margulies, D. H., G. A. Evans, K. Ozato, R. D. Camerini-Otero, K. Tanaka, E. Appella, and J. G. Seidman. 1983. Expression of H-2Dd and H-2Ld mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer. J. Immunol. 130:463-470.
26. d recombinants. J. Exp. Med. 166:327-340.
27. + HIV-1 envelope-specific murine CTLs by short exposure to antigenic peptide. J. Immunol. 169:6588-6593.
28. Bowie, J. U., N. D. Clarke, C. O. Pabo, and R. T. Sauer. 1990. Identification of protein folds: matching hydrophobicity patterns of sequence sets with solvent accessibility patterns of known structures. Proteins. 7:257-264.
29. Ota, M., and K. Nishikawa. 1997. Assessment of pseudo-energy potentials by the best-five test: a new use of the three-dimensional profiles of proteins. Protein Eng. 10:339-351.
30. Sali, A., and T. L. Blundell. 1993. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234:779-815.
31. Fiser, A., R. K. Do, and A. Sali. 2000. Modeling of loops in protein structures. Protein Sci. 9:1753-1773.
32. Baker, D., and A. Sali. 2001. Protein structure prediction and structural genomics. Science. 294:93-96.
33. Marti-Renom, M. A., M. S. Madhusudhan, A. Fiser, B. Rost, and A. Sali. 2002. Reliability of assessment of protein structure prediction methods. Structure. 10:435-440.
34. Achour, A., K. Persson, R. A. Harris, J. Sundback, C. L. Sentman, Y. Lindqvist, G. Schneider, and K. Karre. 1998. The crystal structure of H-2Dd MHC class I complexed with the HIV-1-derived peptide P18-I10 at 2.4 A resolution: implications for T cell and NK cell recognition. Immunity. 9:199-208.
35. Stewart, J. J. P. 1996. Application of localized molecular orbitales to the solution of semiempirical self-consistent field equations. Int. J. Quant. Chem. 58:133-146.
36. Sherman, D. H., P. S. Hochman, R. Dick, R. Tizard, K. L. Ramachandran, R. A. Flavell, and B. T. Huber. 1987. Molecular analysis of antigen recognition by insulin-specific T-cell hybridomas from B6 wild-type and bm12 mutant mice. Mol. Cell. Biol. 7:1865-1872.
37. Tan, K. N., B. M. Datlof, J. A. Gilmore, A. C. Kronman, J. H. Lee, A. M. Maxam, and A. Rao. 1988. The T cell receptorValpha 3 gene segment is associated with reactivity to p-azobenzenearsonate. Cell. 54:247-261.
38. Bill, J., J. Yague, V. B. Appel, J. White, G. Horn, H. A. Erlich, and E. Palmer. 1989. Molecular genetic analysis of 178 I-Abm12-reactive T cells. J. Exp. Med. 169:115-133.
39. Cerasoli, D. M., M. P. Riley, F. F. Shih, and A. J. Caton. 1995. Genetic basis for T cell recognition of a major histocompatibility complex class II-restricted neo-self peptide. J. Exp. Med. 182:1327-1336.
40. Horwitz, M. S., Y. Yanagi, and M. B. Oldstone. 1994. T-cell receptors from virus-specific cytotoxic T lymphocytes recognizing a single immunodominant nine-amino-acid viral epitope show marked diversity. J. Virol. 68:352-357.
41. Plaksin, D., K. Polakova, P. McPhie, and D. H. Margulies. 1997. A three-domain T cell receptor is biologically active and specifically stains cell surface MHC/peptide complexes. J. Immunol. 158:2218-2227.
42. Bowie, J. U., R. Luthy, and D. Eisenberg. 1991. A method to identify protein sequences that fold into a known three-dimensional structure. Science. 253:164-170.
43. Kaye, J., and S. M. Hedrick. 1988. Analysis of specificity for antigen, Mls, and allogenic MHC by transfer of T-cell receptor alpha- and betachain genes. Nature. 336:580-583.
44. Lai, M. Z., Y. J. Jang, L. K. Chen, and M. L. Gefter. 1990. Restricted V-(D)-J junctional regions in the T cell response to lambda-repressor. Identification of residues critical for antigen recognition. J. Immunol. 144:4851-4856.
45. Bellio, M., Y. C. Lone, O. de la Calle-Martin, B. Malissen, J. P. Abastado, and P. Kourilsky. 1994. The V beta complementarity determining region 1 of a major histocompatibility complex (MHC) class I-restricted T cell receptor is involved in the recognition of peptide/MHC I and superantigen/MHC II complex. J. Exp. Med. 179:1087-1097.
46. Lone, Y. C., M. Bellio, A. Prochnicka-Chalufour, D. M. Ojcius, N. Boissel, T. H. Ottenhoff, R. D. Klausner, J. P. Abastado, and P. Kourilsky. 1994. Role of the CDR1 region of the TCR beta chain in the binding to purified MHC-peptide complex. Int. Immunol. 6:1561-1565.
47. Clark, S. P., B. Arden, D. Kabelitz, and T. W. Mak. 1995. Comparison of human and mouse T-cell receptor variable gene segment subfamilies. Immunogenetics. 42:531-540.